Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration.
Yaspan BL, Williams DF, Holz FG, Regillo CD, Li Z, Dressen A, van Lookeren Campagne M, Le KN, Graham RR, Beres T, Bhangale TR, Honigberg LA, Smith A, Henry EC, Ho C, Strauss EC; MAHALO Study Investigators.
Yaspan BL, et al. Among authors: strauss ec.
Sci Transl Med. 2017 Jun 21;9(395):eaaf1443. doi: 10.1126/scitranslmed.aaf1443.
Sci Transl Med. 2017.
PMID: 28637922
Clinical Trial.